Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
In March 2016, nine Brazilian executives received prison sentences from a Brazilian court ranging from 10 to 19 years for their roles in the $35 million Petrobras Scandal, a scheme among construction and engineering companies to submit fraudulent bids to, and bribe agents of, the state-owned oil company, Petroleo Brasileiro SA (Petrobras). Several former Petrobras directors and a manager were also sentenced, some to more than 20 years in prison. The companies' legal troubles did not end there. Currently, Brazil's antitrust authority, the Council for Economic Defense, is investigating 21 companies and 59 executives for antitrust violations in connection with the same Petrobras contracts. The antitrust case was unearthed while investigators were looking into corruption issues. In the U.S., Petrobras investors filed civil suits against the company. And in 2015, Brazilian prosecutors notified the U.S. Department of Justice (DOJ) of evidence that several of the companies' actions may implicate the Foreign Corrupt Practices Act (FCPA).
Meanwhile, in Romania, the authorities have started to focus on pharmaceutical companies for anti-competitive practices. The modus operandi? Paying for state-employed doctors' attendance at Congresses and for “participation” in allegedly questionable clinical trials, ostensibly to induce them to prescribe the company's drugs rather than similar drugs from other companies ' also potential FCPA violations. Catalin Lupasteanu and Livia Ispas, Doctors Who Supported Drugmakers Rewarded With Holidays in France, Canada, USA, MEDIAFAX.RO (July 28, 2015), http://bit.ly/247d13w. These cases are just two examples of antitrust and corruption intersecting within the same set of facts. A company may think it is facing exposure in an antitrust investigation, but ultimately may find itself charged with corruption. With increased agency scrutiny on a global scale, coupled with increased cooperation between prosecutors abroad and in the United States, companies should seize the opportunity now to reassess their antitrust and FCPA compliance policies and procedures.
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
The parameters set forth in the DOJ's memorandum have implications not only for the government's evaluation of compliance programs in the context of criminal charging decisions, but also for how defense counsel structure their conference-room advocacy seeking declinations or lesser sanctions in both criminal and civil investigations.
This article discusses the practical and policy reasons for the use of DPAs and NPAs in white-collar criminal investigations, and considers the NDAA's new reporting provision and its relationship with other efforts to enhance transparency in DOJ decision-making.
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.